Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Novel 17beta-HSD-3 inhibitors and their use claimed by Schering-Plough

Sep. 2, 2004

Cannabinoids found to improve urge incontinence in MS patients

Sep. 2, 2004

Good safety profile reported for darifenacin in OAB

Sep. 2, 2004

New selective beta3-adrenoceptor agonist in development at Mitsubishi

Aug. 31, 2004

Fesoterodine reduces micturition and urge incontinence in UFS

Aug. 31, 2004

Extended-release tolterodine shows efficacy for mixed incontinence in women

Aug. 31, 2004

Yamanouchi to roll out Vesicare in E.U.

Aug. 30, 2004

Orally active nonpeptide aquaretic V2 antagonist advanced to human testing

Aug. 25, 2004

Yamanouchi and Boehringer Ingelheim to copromote Flomax in U.S. for BPH

Aug. 18, 2004

Yentreve approved in E.U. for stress urinary incontinence

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...